Zai Lab and MacroGenics Enter Into Broad Strategic
Zai Lab granted combination of regional Asian and global rights for up to four CD3- or CD47-based bispecific molecules MacroGenics provides rights to Zai Lab for its DART® and TRIDENT® …
Tag: Nasdaq:ZLAB